CS logo
small CS logo
The Centre for Dermatology

Richmond Hill, Ontario, Canada
Dermatologist in Richmond Hill, Ontario
312 Hwy 7, Richmond Hill, ON L4B 1A5

About The Centre for Dermatology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
9
Eli Lilly and Company
5
Dermira, Inc.
3
Amgen
2
Bristol-Myers Squibb
2
Dow Pharmaceutical Sciences
2
LEO Pharma
2
Arcutis Biotherapeutics, Inc.
1
Boehringer Ingelheim
1
Coherus Biosciences, Inc.
1
Concert Pharmaceuticals
1
Total Rows: 16

Clinical Trials at The Centre for Dermatology


During the past decade, The Centre for Dermatology conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 21 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 10 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33334477333333112211002266222255Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis
2009-11-01
2011-12-01
Completed
780
Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis
2010-05-01
2012-10-01
Completed
78
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
2010-09-01
2011-12-01
Completed
180
Phase 3 Papulopustular Rosacea Study
2011-12-01
2013-08-01
Completed
688
Effect of LEO 90100 on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis VulgarisExtensive Psoriasis Vulgaris
2012-05-01
2013-05-01
Completed
37
A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel
2013-08-01
2014-06-01
Completed
114
Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)
2013-12-01
2014-09-01
Completed
69
A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis
2015-05-01
2016-04-01
Completed
212

Rows per page:

1–34 of 34

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "The Centre for Dermatology" #1 sponsor was "Pfizer" with 9 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Dermira, Inc." with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Centre for Dermatology" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator and "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 9Pfizer: 9Eli Lilly and Company: 5Eli Lilly and Company: 5Dermira, Inc.: 3Dermira, Inc.: 3Amgen: 2Amgen: 2Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Dow Pharmaceutical Sciences: 2Dow Pharmaceutical Sciences: 2LEO Pharma: 2LEO Pharma: 2Arcutis Biotherapeutics, Inc.: 1Arcutis Biotherapeutics, Inc.: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1Coherus Biosciences, Inc.: 1Coherus Biosciences, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsDermira, Inc.: 2Dermira, Inc.: 2Incyte Corporation: 2Incyte Corporation: 2

Clinical Trials Conditions at The Centre for Dermatology


According to Clinical.Site data, the most researched conditions in "The Centre for Dermatology" are "Atopic Dermatitis" (8 trials), "Plaque Psoriasis" (5 trials), "Psoriasis" (5 trials), "Acne Vulgaris" (4 trials) and "Dermatitis, Atopic" (3 trials). Many other conditions were trialed in "The Centre for Dermatology" in a lesser frequency.

Clinical Trials Intervention Types at The Centre for Dermatology


Most popular intervention types in "The Centre for Dermatology" are "Drug" (31 trials), "Other" (5 trials), "Biological" (3 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Lebrikizumab" (3 trials), "PF-06700841" (3 trials), "Abrocitinib 200 mg" (2 trials) and "Adalimumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at The Centre for Dermatology


The vast majority of trials in "The Centre for Dermatology" are 34 trials for "All" genders.

Clinical Trials Status at The Centre for Dermatology


Currently, there are NaN active trials in "The Centre for Dermatology". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in The Centre for Dermatology, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in The Centre for Dermatology, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 19Phase 3: 19Phase 2: 14Phase 2: 14Phase 1: 2Phase 1: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 28Completed: 28Active, not recruiting: 5Active, not recruiting: 5Terminated: 1Terminated: 1